Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome
- 30 January 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 21 (3), 373-374
- https://doi.org/10.1097/qad.0b013e328012b84d
Abstract
The objective of this study was to identify prognostic factors of death in patients with tuberculous meningitis (TM) and show the impact of infection by multidrug-resistant strains on the outcome of this disease. We retrospectively analysed clinical charts of HIV-infected patients with culture-confirmed TM attending our institution during 1996–2004. The following variables were associated with death during hospitalization: neurological signs at admission, a CD4 T-cell count less than 50 cells/μl and infection by multidrug-resistant strains.Keywords
This publication has 6 references indexed in Scilit:
- Evaluación de las medidas de control adoptadas frente a la epidemia de tuberculosis multirresistente asociada al sida en un hospital hispanoamericanoEnfermedades Infecciosas y Microbiología Clínica, 2006
- The Influence of HIV Infection on Clinical Presentation, Response to Treatment, and Outcome in Adults with Tuberculous MeningitisThe Journal of Infectious Diseases, 2005
- Effect of Antituberculosis Drug Resistance on Response to Treatment and Outcome in Adults with Tuberculous MeningitisThe Journal of Infectious Diseases, 2005
- Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and AdultsNew England Journal of Medicine, 2004
- Multidrug‐Resistant Tuberculous Meningitis in KwaZulu‐Natal, South AfricaClinical Infectious Diseases, 2004
- Nosocomial Spread of Human Immunodeficiency Virus‐Related Multidrug‐Resistant Tuberculosis in Buenos AiresThe Journal of Infectious Diseases, 1997